My NCBI | Sign In
RSS Settings
  • Search: Barrios Ana[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 14

    1.

    Higher risk of hyperglycemia in HIV-infected patients treated with didanosine plus tenofovir.

    García-Benayas T, Rendón AL, Rodríguez-Novóa S, Barrios A, Maida I, Blanco F, Barreiro P, Rivas P, González-Lahoz J, Soriano V.

    AIDS Res Hum Retroviruses. 2006 Apr;22(4):333-7.PMID: 16623636 [PubMed - indexed for MEDLINE]Related articles

    2.

    Plasma levels of atazanavir and the risk of hyperbilirubinemia are predicted by the 3435C-->T polymorphism at the multidrug resistance gene 1.

    Rodríguez Nóvoa S, Barreiro P, Rendón A, Barrios A, Corral A, Jiménez-Nacher I, González-Lahoz J, Soriano V.

    Clin Infect Dis. 2006 Jan 15;42(2):291-5. Epub 2005 Dec 8.PMID: 16355344 [PubMed - indexed for MEDLINE]Related articles

    3.

    Simplification therapy with once-daily didanosine, tenofovir and efavirenz in HIV-1-infected adults with viral suppression receiving a more complex antiretroviral regimen: final results of the EFADITE trial.

    Barrios A, Negredo E, Domingo P, Estrada V, Labarga P, Asensi V, Morales D, Santos J, Clotet B, Soriano V; EFADITE Study Group.

    Antivir Ther. 2005;10(7):825-32.PMID: 16312178 [PubMed - indexed for MEDLINE]Related articles

    4.

    Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine.

    Barrios A, Rendón A, Negredo E, Barreiro P, Garcia-Benayas T, Labarga P, Santos J, Domingo P, Sánchez-Conde M, Maida I, Martín-Carbonero L, Núñez M, Blanco F, Clotet B, Sambeat MA, Gil P, Gonzalez-Lahoz J, Cooper D, Soriano V.

    AIDS. 2005 Mar 24;19(6):569-75.PMID: 15802975 [PubMed - indexed for MEDLINE]Related articles

    5.

    Estimated extent of cross-resistance to ritonavir-boosted protease inhibitors among protease inhibitors-experienced patients: implications for tipranavir use.

    Gallego O, de Mendoza C, Corral A, Barrios A, Soriano V.

    AIDS Patient Care STDS. 2005 Feb;19(2):67-9. No abstract available. PMID: 15716637 [PubMed - indexed for MEDLINE]Related articles

    6.

    Predictors of virological response to atazanavir in protease inhibitor-experienced patients.

    Barrios A, Rendón AL, Gallego O, Martín-Carbonero L, Valer L, Ríos P, Maida I, García-Benayas T, Jiménez-Nácher I, González-Lahoz J, Soriano V.

    HIV Clin Trials. 2004 Jul-Aug;5(4):201-5.PMID: 15472794 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi's sarcoma.

    Martin-Carbonero L, Barrios A, Saballs P, Sirera G, Santos J, Palacios R, Valencia ME, Alegre M, Podzamczer D, González-Lahoz J; Caelyx/KS Spanish Group.

    AIDS. 2004 Aug 20;18(12):1737-40.PMID: 15280789 [PubMed - indexed for MEDLINE]Related articles

    8.

    Nevirapine-containing regimens in HIV-infected naive patients with CD4 cell counts of 200 cells/microl or less.

    Ferrer E, Santamariña E, Domingo P, Fumero E, Ribera E, Knobel H, Lopez JC, Barrios A, Podzamczer D.

    AIDS. 2004 Aug 20;18(12):1727-9.PMID: 15280785 [PubMed - indexed for MEDLINE]Related articles

    9.

    Tenofovir-related nephrotoxicity in HIV-infected patients.

    Barrios A, García-Benayas T, González-Lahoz J, Soriano V.

    AIDS. 2004 Apr 9;18(6):960-3. No abstract available. PMID: 15060449 [PubMed - indexed for MEDLINE]Related articles

    10.

    Gynecomastia in HIV-infected patients receiving antiretroviral therapy.

    García-Benayas T, Blanco F, Martín-Carbonero L, Valencia E, Barrios A, González-Lahoz J, Soriano V.

    AIDS Res Hum Retroviruses. 2003 Sep;19(9):739-41.PMID: 14585204 [PubMed - indexed for MEDLINE]Related articles

    11.

    Role of baseline human immunodeficiency virus genotype as a predictor of viral response to tenofovir in heavily pretreated patients.

    Barrios A, de Mendoza C, Martín-Carbonero L, Ribera E, Domingo P, Galindo MJ, Gálvez J, Estrada V, Dalmau D, Asensi V, Soriano V.

    J Clin Microbiol. 2003 Sep;41(9):4421-3.PMID: 12958282 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Effect of dietary intervention on highly active antiretroviral therapy-related dyslipemia.

    Barrios A, Blanco F, García-Benayas T, Gómez-Viera JM, de la Cruz JJ, Soriano V, González-Lahoz J.

    AIDS. 2002 Oct 18;16(15):2079-81.PMID: 12370508 [PubMed - indexed for MEDLINE]Related articles

    13.

    SENC (Spanish efavirenz vs. nevirapine comparison) trial: a randomized, open-label study in HIV-infected naive individuals.

    Núñez M, Soriano V, Martín-Carbonero L, Barrios A, Barreiro P, Blanco F, García-Benayas T, González-Lahoz J.

    HIV Clin Trials. 2002 May-Jun;3(3):186-94.PMID: 12032877 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Lipodystrophy body-shape changes in a patient undergoing zidovudine monotherapy.

    García-Benayas T, Blanco F, Gómez-Viera JM, Barrios A, Soriano V, González-Lahoz J.

    AIDS. 2002 May 3;16(7):1087-9. No abstract available. PMID: 11953483 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    1 free full-text article in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity